Breast cancer with negative estrogen receptor (ER), negative progesterone receptor (PR), and negative human epidermal growth factor receptor 2 (HER2) expression is pathologically defined as triple-negative breast cancer (TNBC) [2]. This evidence concerns the gene ERBB2 and breast cancer.